Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma
- PMID: 18537985
- DOI: 10.1111/j.1365-2222.2008.03009.x
Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma
Abstract
Background: Eosinophilic infiltration into the airways is frequently associated with allergic asthma; however, the role of antigen deposition in mediating this phenomenon has not been studied in detail.
Objective: Using a murine model of ovalbumin (OVA) allergy, we examined how differential deposition of OVA during antigen challenge affects pulmonary eosinophilia, immune response and airway hyper-reactivity (AHR).
Methods: Differential allergen deposition to the upper respiratory tract (URT) alone or combined upper and lower respiratory tract (ULRT) was accomplished by administering OVA intranasally to either anaesthetized or unanaesthetized mice, respectively. BALB/c mice (6-7 weeks old) were sensitized with OVA-alum via the intraperitoneal route, and then challenged intranasally using OVA, with or without anaesthesia. AHR, enumeration of inflammatory cells and quantitative measurement of inflammatory cytokines and chemokines in bronchoalveolar lavage fluid (BALF), lung histopathology and immune responses were subsequently assessed.
Results: In sensitized animals challenged via the ULRT route, a profound eosinophilia and goblet cell hyperplasia was observed in lung tissue. Conversely, sensitized mice receiving an identical challenge dose via the URT route alone exhibited only negligible levels of inflammation. Interestingly, AHR and OVA-specific IgG(1) and IgE systemic responses were comparable between the two groups.
Conclusion: This study indicates that direct exposure of allergen in the deep lung is highly correlated with airway eosinophilia and lung inflammation, but does not correlate with AHR or immune response.
Similar articles
-
4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.Clin Exp Allergy. 2006 Mar;36(3):377-85. doi: 10.1111/j.1365-2222.2006.02445.x. Clin Exp Allergy. 2006. PMID: 16499650
-
Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma.Clin Exp Allergy. 2005 Aug;35(8):1104-11. doi: 10.1111/j.1365-2222.2005.02301.x. Clin Exp Allergy. 2005. PMID: 16120094
-
Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.Clin Exp Allergy. 2008 Oct;38(10):1668-79. doi: 10.1111/j.1365-2222.2008.03036.x. Epub 2008 Jun 25. Clin Exp Allergy. 2008. PMID: 18631348
-
Do mouse models of allergic asthma mimic clinical disease?Int Arch Allergy Immunol. 2004 Jan;133(1):84-100. doi: 10.1159/000076131. Epub 2004 Jan 12. Int Arch Allergy Immunol. 2004. PMID: 14726635 Review.
-
Endobronchial allergen challenge.Eur Respir J Suppl. 1998 Mar;26:33S-35S. Eur Respir J Suppl. 1998. PMID: 9585878 Review.
Cited by
-
Chemical respiratory sensitization-Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers.Front Toxicol. 2024 Jul 29;6:1331803. doi: 10.3389/ftox.2024.1331803. eCollection 2024. Front Toxicol. 2024. PMID: 39135743 Free PMC article. Review.
-
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System.J Vis Exp. 2017 Apr 6;(122):55454. doi: 10.3791/55454. J Vis Exp. 2017. PMID: 28448027 Free PMC article.
-
Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.Infect Immun. 2012 Mar;80(3):1007-14. doi: 10.1128/IAI.06078-11. Epub 2012 Jan 17. Infect Immun. 2012. PMID: 22252865 Free PMC article.
-
Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation.Clin Exp Immunol. 2010 May;160(2):266-74. doi: 10.1111/j.1365-2249.2009.04084.x. Epub 2010 Feb 2. Clin Exp Immunol. 2010. PMID: 20132231 Free PMC article.
-
Practical Considerations in Dose Extrapolation from Animals to Humans.J Aerosol Med Pulm Drug Deliv. 2024 Apr;37(2):77-89. doi: 10.1089/jamp.2023.0041. Epub 2024 Jan 17. J Aerosol Med Pulm Drug Deliv. 2024. PMID: 38237032 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical